Jonathan Finn, Director at ATOSSA THERAPEUTICS, INC. (ATOS), bought 25,000 shares at $1.77 ($44K) on 2024-04-10, disclosed to the SEC on 2024-04-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.